ArticleBMC pediatrics2026
Time to treatment failure and its predictors among children attending antiretroviral therapy in Jimma, southwest Ethiopia: a retrospective cohort study.
Article in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTreatment failure of antiretroviral therapy (ART) has become an increasingly global health issue. In Ethiopia, prior studies on ART failure rates have focused primarily on adults in hospital settings with varying definitions of treatment failure, leaving pediatric data scarce. Thus, this study aimed to determine the incidence rate of treatment failure and its predictors among children enrolled in first-line ART in Jimma, Ethiopia.
methodsA retrospective cohort study was conducted at health facilities in Jimma, Ethiopia. A total of 312 children who were enrolled in first-line ART from January 2015 to December 2024 were selected via systematic random sampling. The data were retrieved by reviewing the child’s medical records and analyzed using Stata software. We utilized a multivariable Cox regression model to identify predictors of treatment failure and adjusted hazards ratio (AHR) with 95% confidence intervals (CI) to measure the associations. A p-value < 0.05 was used to declare statistically significant associations.
resultsThe proportion of pediatric first-line ART failure in this study was 15.71% (95% CI: 11.57, 19.85), with an overall incidence density of 2.07 per 1,000 person-months (95% CI: 1.56, 2.74). The predictors significantly associated with ART failure were underweight (AHR = 3.95, 95% CI: 1.63, 9.57), anemia (AHR = 3.01, 95% CI: 1.51, 6.01), delayed ART initiation (AHR = 3.46, 95% CI: 1.32, 9.06), fair or poor adherence (AHR = 11.36, 95% CI: 5.22, 24.73), and advanced HIV disease (AHR = 2.49, 95% CI: 1.34, 4.66). Conversely, caregivers with positive serostatus (AHR = 0.191, 95% CI: 0.078, 0.46) and children aged 10–14 years (AHR = 0.064, 95% CI: 0.023, 0.17) had a significantly reduced risk of failure compared with their counterparts.
conclusionFirst-line ART failure among children remains high, rendering achieving the nation’s HIV-free generation target difficult. To improve pediatric HIV outcomes in Ethiopia, future interventions should focus on rapid ART initiation, adherence counseling, nutritional support, and early anemia screening and management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.